|1.||Fleming, Timothy P: 12 articles (02/2013 - 05/2002)|
|2.||Mohanakumar, T: 7 articles (10/2014 - 05/2003)|
|3.||Gillanders, William E: 6 articles (12/2014 - 05/2008)|
|4.||Tiriveedhi, Venkataswarup: 4 articles (12/2014 - 05/2011)|
|5.||Nordgård, Oddmund: 4 articles (01/2014 - 07/2009)|
|6.||Tjensvoll, Kjersti: 4 articles (01/2014 - 07/2009)|
|7.||Gilje, Bjørnar: 4 articles (01/2014 - 07/2009)|
|8.||Goedegebuure, Peter S: 4 articles (02/2013 - 01/2003)|
|9.||Jaramillo, Andrés: 4 articles (01/2012 - 12/2002)|
|10.||Dietz, Jill R: 4 articles (08/2008 - 05/2003)|
|1.||Breast Neoplasms (Breast Cancer)
08/01/2015 - "We have demonstrated previously that gross cystic disease fluid protein-15 (GCDFP-15) and mammaglobin A (MAM) are of limited utility in triple-negative breast cancer (TNBC). "
01/01/2015 - "Mammaglobin A (MGA) is an organ specific molecular biomarker for metastatic breast cancer diagnosis. "
01/01/2014 - "In addition, mammaglobin A is currently under inves tigation as a potential therapeutic target for immune therapies that target breast cancer. "
01/01/2013 - "Recombinant mammaglobin A adenovirus-infected dendritic cells induce mammaglobin A-specific CD8+ cytotoxic T lymphocytes against breast cancer cells in vitro."
01/01/2013 - "Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer."
01/01/2015 - "Characterization of anti-tumor T cell responses highlighted sustained levels of CD8(+) T cells specific for survivin and mammaglobin-A throughout NC in patients undergoing a pCR in both arms. "
12/01/2014 - "Mammaglobin-A (MAM-A) is overexpressed in 40% to 80% of primary breast cancers. "
10/01/2014 - "Mammaglobin-A (MAM-A) is a secretory protein that is overexpressed in 80 % of human breast cancers. "
09/15/2004 - "Passive transfer of mammaglobin-A-reactive CTLs into SCID (severe combined immunodeficient) beige mice with actively growing mammaglobin-A+ tumors resulted in statistically significant regression (P<.001) in the growth of the tumors. "
06/01/2005 - "In the current study we further investigated the mechanism of protein transduction, utilizing the breast cancer-associated protein, mammaglobin-A, which is expressed in about 80% of breast cancers. "
01/01/2009 - "Mammaglobin, a valuable diagnostic marker for metastatic breast carcinoma."
07/01/2006 - "We conclude that real-time qRT-PCR assays for mammaglobin 1 are more sensitive and specific that qualitative RT-PCR assays for the detection of metastatic breast carcinoma in axillary SLN, but it should not be regarded as a possible substitute for an extensive histopathological scrutiny of the SLN in the clinical practice."
10/01/2003 - "We investigated mammaglobin A expression in metastatic carcinomas of lymph nodes from the breast and various other organs and its usefulness in identifying metastatic carcinoma of the breast. "
07/01/2014 - "Mammaglobin-A immunohistochemistry in primary central nervous system neoplasms and intracranial metastatic breast carcinoma."
11/01/2012 - "Mammaglobin 1 expression was assessed immunohistochemically in endometrial samples from 60 normal fertile patients throughout the menstrual cycle, in 49 endometriotic tissue samples, in 15 endometrial adenocarcinomas, and in 36 breast carcinomas. "
|4.||Neoplasm Metastasis (Metastasis)
09/01/2006 - "Mammaglobin A was detected in 7/39 (17.9%) of patients with verified metastasis. "
11/01/2012 - "The secretoglobin mammaglobin 1 (MGB1) is strongly expressed in breast tumours, and is therefore used to detect breast cancer metastases, although it has also been detected in other tissues. "
02/01/2011 - "In vivo selectivity was determined by i.v. injection of MamAb-680 into mice with mammaglobin-A-positive and -negative mammary fat pad (MFP) tumors; and by peritumoral MFP injection of the targeted imaging probe in mice with spontaneous ALN metastases. "
02/01/2011 - "A mammaglobin-A targeting agent for noninvasive detection of breast cancer metastasis in lymph nodes."
01/01/2009 - "Analysis of the immunohistochemical expression of mammaglobin A in primary breast carcinoma and lymph node metastasis."
|5.||Circulating Neoplastic Cells
09/01/2006 - "Mammaglobin A is a highly specific molecular marker for the detection of circulating tumor cells in operable breast cancer, with important prognostic applications."
04/01/2011 - "Human mammaglobin: a superior marker for reverse-transcriptase PCR in detecting circulating tumor cells in breast cancer patients."
05/01/2008 - "To investigate the prognostic value of the molecular detection of circulating tumor cells (CTCs) using three markers [cytokeratin 19 (CK19), mammaglobin A (MGB1), and HER2] in early breast cancer. "
05/01/2008 - "Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer."
09/01/2006 - "The development and validation of a nested RT-PCR methodology for the detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer and evaluation of its prognostic significance. "
|1.||DNA (Deoxyribonucleic Acid)
|4.||Messenger RNA (mRNA)
|5.||Complementary DNA (cDNA)
|7.||Keratin-19 (Keratin 19)
|9.||T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)
|2.||Heterologous Transplantation (Xenotransplantation)